Market revenue in 2022 | USD 2.7 million |
Market revenue in 2030 | USD 4.6 million |
Growth rate | 6.9% (CAGR from 2022 to 2030) |
Largest segment | Morphine |
Fastest growing segment | Clonidine |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 33.33% in 2022. Horizon Databook has segmented the UAE intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
The UAE accounted for the second-largest share in the intrathecal pumps market in the MEA region in 2020. Hospitals are collaborating with government organizations to provide excellent healthcare services, thus generating revenue through medical tourism.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE intrathecal pumps market, including forecasts for subscribers. This country databook contains high-level insights into UAE intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account